Study Title
Evaluation of 64Cu-ATSM PET/CT in Predicting Neo Adjuvant Treatment Response in Locally Advanced Rectum Cancer
Study Details
Description:
This phase II trial is assessing how 64Cu-ATSM (64Cu-copper(II) diacetylbis(N4-methylthiosemicarbazone)) PET/CT scan could predict neo adjuvant treatment response in rectum cancer locally advanced
Sponsor:
Institut Cancerologie de l'Ouest
Contacts:
Mathilde COLOMBIE, MDmathilde.colombie@ico.unicancer.fr
+33240679900 ext 9501
Nadia ALLAM, PhDnadia.allam@ico.unicancer.fr
+33240679826
Government Study Link:
NCT03951337 - Click here to see study onClinicalTrials.gov